Waldencast plc

Waldencast plc is a global multi-brand beauty and wellness platform established with the mission to create, acquire, accelerate, and scale high-growth, purpose-driven brands. Legally domiciled in Jersey, Channel Islands, the company maintains major operating brand hubs in New York City and Long Beach, California.

Historically, Waldencast's portfolio was concentrated in two primary segments: Obagi Medical, specializing in clinically positioned skincare, and Milk Makeup, a digitally native prestige makeup brand. Obagi Medical offered advanced skincare products designed to address signs of aging, hyperpigmentation, and fine lines, including injectable hyaluronic acid gels. Milk Makeup provides a range of clean, cruelty-free cosmetics and skincare products, distributed through its e-commerce platform and major retailers like Sephora and Ulta Beauty. The company operates within the prestige beauty, physician-dispensed skincare, and color cosmetics market segments, with a strong presence in North America and international distribution.

In a significant strategic move, Waldencast announced the sale of its Obagi Medical business to Bridgepoint in May 2026, a transaction expected to close in the third quarter of 2026. This divestiture aims to reduce the company's debt and sharpen its focus on the Milk Makeup brand. Additionally, Waldencast announced in April 2026 the conclusion of a U.S. Securities and Exchange Commission investigation, with no enforcement action recommended against the company. Founded by Michel Brousset, who serves as CEO, and Hind Sebti, Waldencast continues to evolve its market positioning as a platform for conscious and purpose-driven beauty brands.